RAD51C and breast cancer: A total of 313 patients were identified as carrying at least one of 13 BC susceptibility gene mutations, and 38 patients carried 35 distinct pathogenic/likely pathogenic variants in 12 FA genes (BRCA1/2, PALB2 and RAD51C were not included).